Study finds evidence for repurposing thiostrepton as an anti-rhabdomyosarcoma drug Post author:admin Post published: October 27, 2025 Post category:uncategorized Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. You Might Also Like Biden pick to lead NIH finally has her day, but still gets caught up in drug price debate October 19, 2023 Heart scan study reveals low-fiber diets drive dangerous heart plaques June 18, 2025 Denmark study: Air pollution tied to increased risk of dementia May 19, 2024
Biden pick to lead NIH finally has her day, but still gets caught up in drug price debate October 19, 2023